Modified bladder outlet obstruction index for powerful efficacy prediction of transurethral resection of prostate with benign prostatic hyperplasia
BMC Urology Dec 10, 2021
Liu H, Tian Y, Luo G, et al. - In benign prostate hyperplasia (BPH) patients, the clinical symptoms and surgical efficacy can be predicted to a certain extent by both modified bladder outlet obstruction index (MBOOI) and bladder outlet obstruction index (BOOI), but MBOOI, in comparison to BOOI, affords a likely more useful factor that can aid the prediction of the surgical efficacy of transurethral resection of the prostate (TURP).
A total of 403 patients with BPH were analyzed to determine the clinical value of the MBOOI and its use in predicting surgical efficacy in men undergoing TURP.
Estimation of BOOI and MBOOI was done, and surgical efficacy was determined by the improvements in International Prostate Symptom Score (IPSS), quality of life (QoL), and Q max 6 months post-surgery.
On comparing effective and ineffective groups depending on the overall efficacy, it was noted that there were significant differences in prostate-specific antigen, intra-vesical pressure, detrusor pressure at maximum urine flow rate, abdominal pressure, BOOI, MBOOI, transitional zone volume (TZV), transitional zone index (TZI), IPSS total score, IPSS voiding score, IPSS storage score, Q max , and post void residual at baseline.
In binary logistic regression analysis, MBOOI was shown to be the only baseline parameter that showed correlation with the improvements in IPSS, QoL, Q max , and the overall efficacy.
By ROC analysis, MBOOI was more optimal compared with BOOI, TZV and TZI in predicting surgical efficacy.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries